Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $1.06 Trillion
  • Q3 2025

Adar1 Capital Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.06 Trillion distributed in 220 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Abivax Sa with a value of $115B, Keros Therapeutics, Inc. with a value of $85.3B, Protagonist Therapeutics, Inc with a value of $65.7B, Roivant Sciences Ltd. with a value of $50.6B, and Ea Series Trust with a value of $38.4B.

Examining the 13F form we can see an increase of $412B in the current position value, from $652B to 1.06T.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.06 Trillion
Healthcare: $648 Billion
ETFs: $83.7 Billion
Communication Services: $996 Million
Consumer Cyclical: $989 Million
Technology: $689 Million
Financial Services: $531 Million
Basic Materials: $312 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$443M
$4.1 Billion 0.39% of portfolio
978,894
Q3 2025 Added 9,312.44%
Nektar Therapeutics
-
$4.1 Billion 0.38% of portfolio
-
Q3 2025 Added 355.86%
$1.55B
$3.72 Billion 0.35% of portfolio
90,688
Q3 2025 Added 262.75%
$130B
$3.5 Billion 0.33% of portfolio
74,212
Q3 2025 Added 642.12%
$5.29B
$3.27 Billion 0.31% of portfolio
18,523
Q3 2025 New
-
$3.25 Billion 0.31% of portfolio
-
Q3 2025 Added 1.78%
$451M
$3.14 Billion 0.3% of portfolio
341,612
Q3 2025 Added 540.33%
$4.4B
$3.14 Billion 0.29% of portfolio
33,313
Q3 2025 Added 81.91%
Mineralys Therapeutics Inc
-
$2.97 Billion 0.28% of portfolio
-
Q3 2025 Reduced 74.1%
Kiniksa Pharmaceuticals Intl
-
$2.92 Billion 0.27% of portfolio
-
Q3 2025 Added 32.98%
Zura Bio LTD
-
$2.82 Billion 0.27% of portfolio
-
Q3 2025 Reduced 34.62%
$1.2B
$2.83 Billion 0.27% of portfolio
109,442
Q3 2025 Added 90.45%
$111B
$2.74 Billion 0.26% of portfolio
7,000
Q3 2025 New
Bridgebio Pharma Inc
-
$2.81 Billion 0.26% of portfolio
-
Q3 2025 Reduced 99.0%
$24.1B
$2.52 Billion 0.24% of portfolio
18,000
Q3 2025 Added 252.94%
$3.94B
$2.58 Billion 0.24% of portfolio
31,484
Q3 2025 Added 125.5%
$3.69B
$2.34 Billion 0.22% of portfolio
53,656
Q3 2025 New
A Spac Iii Acquisition Corp
-
$2.22 Billion 0.21% of portfolio
-
Q1 2025 New
$9.05B
$2.25 Billion 0.21% of portfolio
4,895
Q3 2025 Added 364.42%
$1.15B
$2.19 Billion 0.21% of portfolio
101,704
Q3 2025 Reduced 40.38%
$7.94B
$2.21 Billion 0.21% of portfolio
15,000
Q3 2025 New
$3.67B
$2.13 Billion 0.2% of portfolio
102,969
Q3 2025 Added 758.08%
$498M
$1.98 Billion 0.19% of portfolio
205,409
Q3 2025 Reduced 1.16%
Cidara Therapeutics Inc
-
$2.06 Billion 0.19% of portfolio
-
Q2 2025 Added 2.79%
Korro Bio Inc
-
$1.93 Billion 0.18% of portfolio
-
Q3 2025 Reduced 41.53%
$231M
$1.88 Billion 0.18% of portfolio
575,800
Q3 2025 Added 108.77%
-
$1.75 Billion 0.16% of portfolio
-
Q3 2025 Added 234.44%
$1.4B
$1.69 Billion 0.16% of portfolio
170,000
Q1 2025 New
$4.77B
$1.69 Billion 0.16% of portfolio
56,200
Q3 2025 Added 24.89%
$4.37B
$1.72 Billion 0.16% of portfolio
49,800
Q3 2025 Reduced 9.78%
Soleno Therapeutics Inc
-
$1.71 Billion 0.16% of portfolio
-
Q3 2025 Added 45.59%
$671M
$1.6 Billion 0.15% of portfolio
215,752
Q3 2025 New
$235B
$1.56 Billion 0.15% of portfolio
18,540
Q3 2025 Added 163.35%
$2.39B
$1.49 Billion 0.14% of portfolio
37,000
Q3 2025 Added 3.06%
Cohen Circle Acquisit Corp I
-
$1.54 Billion 0.14% of portfolio
-
Q3 2025 New
$72.1M
$1.52 Billion 0.14% of portfolio
891,183
Q3 2025 Reduced 2.73%
$891M
$1.51 Billion 0.14% of portfolio
128,865
Q3 2025 Added 50.15%
Ww Intl Inc
-
$1.44 Billion 0.13% of portfolio
-
Q3 2025 New
$191M
$1.41 Billion 0.13% of portfolio
193,934
Q3 2025 Reduced 22.32%
$70.5M
$1.26 Billion 0.12% of portfolio
775,034
Q3 2025 Added 442.14%
$2.6B
$1.3 Billion 0.12% of portfolio
53,666
Q3 2025 Reduced 81.92%
$141B
$1.13 Billion 0.11% of portfolio
44,400
Q3 2025 Added 12.69%
Best Spac I Acquisition Corp
-
$1.02 Billion 0.1% of portfolio
-
Q2 2025 New
$4.15B
$1.02 Billion 0.1% of portfolio
11,842
Q2 2025 New
Grace Therapeutics Inc
-
$1.04 Billion 0.1% of portfolio
-
Q3 2025 Added 98.41%
$472M
$1.09 Billion 0.1% of portfolio
151,495
Q3 2025 Added 341.5%
Contineum Therapeutics Inc
-
$916 Million 0.09% of portfolio
-
Q3 2025 Reduced 53.26%
$55.8B
$996 Million 0.09% of portfolio
4,936
Q3 2025 New
$25B
$986 Million 0.09% of portfolio
10,000
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 220
  • Current Value $1.06 Trillion
  • Prior Value $652 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 47 stocks
  • Additional Purchases 67 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 52 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email